Regulatory Aspects Towards Approval of Nanomedicine

Nanomedicines have been in the forefront of pharmaceutical research in the last decades, creating new challenges for research community, industry, and regulators. There is a strong demand for the fast development of scientific and technological tools to address unmet medical needs, thus improving human health care and life quality. Tremendous advances in the biomaterials and nanotechnology fields have prompted their use as promising tools to overcome important drawbacks, mostly associated to the non-specific effects of conventional therapeutic approaches. However, the wide range of application of nanomedicines demands a profound knowledge and characterization of these complex products. Their properties need to be extensively understood to avoid unpredicted effects on patients, such as potential immune reactivity. Research policy and alliances have been bringing together scientists, regulators, industry, and, more frequently in recent years, patient representatives and patient advocacy institutions. In order to successfully enhance the development of new technologies, improved strategies for research-based corporate organizations, more integrated research tools dealing with appropriate translational requirements aiming at clinical development, and proactive regulatory policies are essential in the near future. This review focuses on the most important aspects currently recognized as key factors for the regulation of nanomedicines, discussing the efforts under development by industry and regulatory agencies to promote their translation into the market.

 

  • Nanomedicine: Prospects, Risks and Regulatory Issues
  • Current , Future Applications and Regulatory challenges
  • Research Policy and Alliances
  • Regulatory Policies
  • Regulation of Nanomedicines

Related Conference of Regulatory Aspects Towards Approval of Nanomedicine

December 05-06, 2022

World Congress on Precision and Personalized Medicine

Zurich, Switzerland
December 07-08, 2022

9th Asian Herbal and Traditional Medicine summit

Paris, France
December 07-08, 2022

14th World Congress on Personalized Medicine and Novel Therapy

Singapore City, Singapore
December 12-13, 2022

5th International Pharmacy and Pharmaceutical Conference

Dublin, Ireland
February 14-15, 2023

8th Pharmaceutical Chemistry Conference

Paris, France
February 20-21, 2023

20th Annual Meet on Pharmaceutical Sciences

Rome, Italy
March 10-11, 2023

Global Pharmaceutical and Pharma Industry Conference

Brussels, Belgium
March 13-14, 2023

33rd Annual European Pharma Congress

Frankfurt, Germany
March 27-28, 2023

16th Global Pharmacovigilance & Clinical Trials Summit

Vancouver, Canada
April 03-04, 2023

16th European Biosimilars Congress

Barcelona, Spain
April 25-26, 2023

4th Annual Congress on Antibiotics and Bacterial Infections

Amsterdam, Netherlands
May 07-08, 2023

Advanced-Materials 2023

Valencia, Spain
July 25-26, 2023

36th World Congress on Pharmacology

Amsterdam, Netherlands
August 11-12, 2023

38th World Congress on Pharmacology and Therapeutics

Singapore City, Singapore
August 28-29, 2023

23rd International Pharmaceutical Conference and Expo

Vancouver, Canada
September 06-30, -0001

16th World Drug Delivery Summit

London, UK
September 14-15, 2023

10th international conference on Physiotherapy

Bangkok, Thailand
September 27-28, 2023

3rd World Congress on Rare Diseases & Orphan Drugs

Amsterdam, Netherlands
September 27-28, 2023

8th International Conference on Future Pharma and Innovations

Amsterdam, Netherlands
October 09-10, 2023

20th International Conference on Pharmaceutical Chemistry

Barcelona, Spain
November 09-10, 2023

11th International Conference on Clinical Trials

London, UK

Regulatory Aspects Towards Approval of Nanomedicine Conference Speakers

Recommended Sessions

Related Journals

Are you interested in